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Abstract  Background: The important role of food bioactive compounds in the reduction of cancer risk has been 
highlighted by extensive research over the last two decades. Consumption of cruciferous vegetables in particular, rather than 
vegetables as a group has drawn a great deal of attention in cancer research due to their potential protective properties. The 
health benefits of cruciferous vegetables have been well reported being attributed to their rich sources of isothiocyanates and 
indole constituents. This paper focused on the activity of isothiocyanate constituents in breast cancer. Methods: Studies and 
data sources: Medline and Pubmed were searched for studies using key terms isothiocyanate and breast cancer as text words 
and as exploded subject headings where possible. Other key terms such as sulforaphane, benzyl isothiocyanate, phenethyl 
isothiocyanate, allyl isothiocyanate and breast cancer were also searched to check for appropriate studies. The search 
included all studies published from 1995 up to December 2015. Relevant studies cited in the primary-search published before 
1995 were also included in the review. Inclusion criteria: The following inclusion criteria were applied in the screening of 
articles: 1) study published in English; 2) study compared ITC treated group with a control; 3) study examined breast cancer 
tumour or breast cancer cells; 4) study examined anticancer effect; 5) statistical analysis was provided. The search resulted in 
3 human clinical trials and 49 preclinical in vivo and in vitro studies. Results & Discussion: There were substantial 
preclinical data over the last two decades, which reported the activity of various isothiocyanate constituents in breast cancer 
cell lines and animal models of breast cancer tumour, with a limited number of studies from human clinical trials. Recent 
studies have also found that isothiocyanates exhibited significant activity against breast cancer stem cells as well as breast 
cancer bull cells, which is generally thought as a new and innovative approach for targeting breast cancer treatment. The most 
extensively investigated cruciferous vegetables’ active constituents included sulforaphane, benzyl isothiocyanate and 
phenethyl isothiocyanate, and overall, at pharmacological concentration range of 1-10 µM for sulforaphane and 2.5-5 µM for 
benzyl isothiocyanate, and phenethyl isothiocyanate with a wide undefined, varied range of concentrations, these food 
bioactive compounds demonstrated a highly desirable activity at the cellular and molecular levels, therefore they are likely to 
show great promise for use in humans as anti-cancer therapeutic agents. 
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1. Introduction 
Over the last two decades, there has been growing 
research interest that focused on the health benefits of 
cruciferous vegetables in the prevention of cancer of various 
sites, including breast cancer. The cancer protective effects 
of these vegetables have been well believed to be due to the 
active constituents glucosinolates as well as the indole 
compounds, this article will focus specifically on the main 
isothiocyanate constituents, including sulforaphane, benzyl 
isothiocyanate, phenethyl isothiocyanate and will also 
highlight relevant published human studies which examined 
the association between cruciferous vegetables intake and  
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breast cancer risk in patients. The chemical structures of the 
main active isothiocyanate constituents from cruciferous 
vegetables are provided in Figure 1. 
2. Methods 
Studies and data sources 
Medline and Pubmed were searched for studies using key 
terms isothiocyanate and breast cancer as text words and as 
exploded subject headings where possible. Other key terms 
such as cruciferous vegetables, sulforaphane, benzyl 
isothiocyanate, phenethyl isothiocyanate, allyl 
isothiocyanate, and breast cancer were also searched to 
check for appropriate studies. The search included all studies 
published from 1995 up to December 2015. Relevant studies 
cited in the primary-search published before 1995 and 
clinical studies examined cruciferous vegetables intake and 
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breast cancer risk in patients were also screened and 
discussed in the review.  
Inclusion criteria 
The following inclusion criteria were applied in the 
screening of articles from published animal models of breast 
tumour, cancer: 1) study published in English; 2) study 
compared ITC treated group with a control; 3) study 
examined breast cancer tumour or breast cancer cells; 4) 





Benzyl isothiocyanate (BITC) 
 
Phenethyl isothiocyanate (PEITC) 
 
Allyl isothiocyanate (AITC) 
Figure 1.  Chemical structures of isothiocyanate constituents from 
cruciferous vegetables 
3. Results  
The search resulted in a total of 4 clinical studies, 9 animal 
models and 40 in vitro breast cancer cell culture studies. No 
human randomised control trial that examined the outcomes 
of in take of cruciferous vegetables or isothiocyanates in 
breast cancer patients was identified from the literature 
search. Two of the four clinical studies identified were 
human case-control trials and these trials overall reported a 
reduced cancer risk associated with cruciferous vegetables 
consumption. Specifically, in a study involved 2832 patients, 
consumption of cruciferous vegetables was found to be 
inversely associated with breast cancer risk (RR = 0.58, 95% 
CI (0.42-0.79), P = 0.03) (Terry et al., 2001). In another 
study of 740 patients, reduced breast cancer risk was 
reported to be associated with broccoli consumption (OR = 
0.60, 95% CI (0.40-1.01), P = 0.058 (Ambrosone et al., 2004). 
It was worth to note that the finding in the later study did not 
reach statistical significance at P < 0.05. The other two 
clinical trials were both pilot studies, which examined 
pharmacokinetics of intake of broccoli and isothiocyanates 
constituents in healthy women or individuals (Atwell et al., 
2015; Cornblatt et al., 2007). Overall, although the findings 
from published clinical case-control trials were not all 
significant outcomes; they do provide some good evidence to 
support the potential protective role of cruciferous 
vegetables in breast cancer patient. 
The activity reported from published animal models of 
breast cancer appeared to be variable and the reported results 
seemed to be dependent partly on the experimental model 
being employed. Three studies, which utilised a transgenic 
mice model, reported no significant difference in mammary 
tumour growth between benzyl or phenethyl isothiocyanate 
treated versus the control groups (Kim et al., 2013; Singh   
et al., 2012; Warin et al., 2009). However, in another study 
which employed a different human breast cancer xenograft 
model of nude mice injected with MDA-MB-231-cells, it 
was found that benzyl isothiocyanate had activity in reducing 
the tumour volume (Warin et al., 2010). Another study, 
which used a rat model of NMU-induced mammary cancer, 
reported that at concentration of 50µM/kg animal’s body 
weight for 2 weeks of treatment, the phenethyl 
isothiocyanate decreased the percentage of rats with 
mammary tumour phenethyl isothiocyanate was later 
investigated by and colleagues (Aras et al., 2013). In addition, 
phenethyl isothiocyanate has also been found to have 
inhibitory activity in breast tumour metastasis, migration of 
mammary tumour to other site, the brain, however, this study 
did not specifically examine the compound’s activity on 
mammary tumour incidence (Gupta et al., 2013). A brief 
summary of activity investigated in each of the published 
animal models of breast cancer tumours, which examined 
sulforaphane, benzyl isothiocyanate, or phenethyl 
isothiocyanate are provided in Table 1. 
The ability of isothiocyanates to target breast cancer stem 
cells had also been investigated for sulforaphane (Li et al., 
2010) and benzyl isothiocyanate (Kim et al., 2013). In these 
studies, activity against breast cancer stem cells was based 
on the concept that a small population of breast cancer cells 
is the stem cells and these cells express a marker, known as 
CD44high/CD24low/ESA+, which can be measured 
quantitatively. Moreover, the stem cells also display specific 
enzymatic activity namely aldehyde dehydrogenase 1 
(ALDH1+), as well as have the ability to form a distinctive 
morphological structure called mammospheres. The 
mechanism underlying the activity against breast cancer 
stem cells of tested compounds has been hypothesised due to 
inhibition of the receptor tyrosine kinase, known as Ron, this 
receptor functions to drive stemness in breast cancer cells. In 
these studies, sulforaphane, and benzyl isothiocyanate 
significantly reduced population of cells expressing 
CD44high/CD24low/ESA+, decreased the number or size of 
mammospheres formed, and decreased ALDH1+ activity 
(Kim et al., 2013; Li et al., 2010).  
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Anticancer activity of isothiocyanates from cruciferous 
vegetables has also been studied extensively in several types 
of breast cancer cell lines, with MCF-7 and MDA-MB-231 
cells being the most commonly used. Collectively, at 
pharmacological concentration range of 1-10 µM for 
sulforaphane and 2.5-5 µM for benzyl isothiocyanate, and 
phenethyl isothiocyanate with a wide undefined, varied 
range of concentrations, the three most investigated food 
bioactive isothiocyanate constituents demonstrated a highly 
desirable activity at the cellular and molecular levels, 
therefore they are likely to show great promise for use in 
humans as anti-cancer therapeutic agents. 
In summary, although limited clinical evidence is 
available at present, substantial published preclinical data 
exists on anticancer activity of isothiocyanates from 
cruciferous vegetables sulforaphane, benzyl isothiocyanate 
and phenethyl isothiocyanate. Among these most extensively 
investigated constituents, the activity of sulforaphane was 
most consistently reported and benzyl isothiocyanate 
appeared to be relatively the most potent compound, with the 
least required concentration or concentration range for its 
anticancer activity pharmacologically. Based mainly on cell 
culture studies and animal models of breast cancer tumours, 
isothiocyanate compounds clearly demonstrated highly 
desirable activity in both in vitro and in vivo and show great 
promise for use in humans as potential chemopreventive 
agents for breast cancer.   
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